SCHEMBL6837741

SCHEMBL6837741

FC(F)(F)c1nc2cc(Cl)ccc2c2c1nc(-c1ccco1)n2CCC1CCNCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 3/20 0.37
PIM1 P11309 3/20 0.36
PIK3R1 P27986 2/20 0.35
PIK3CA P42336 2/20 0.35
ALDH1A1 P00352 3/20 0.33
LMNA P02545 2/20 0.33
KDM4E B2RXH2 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CNR2 P34972 1/20 0.33
KCNH2 Q12809 2/20 0.32
HRH1 P35367 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
ACP1 P24666 1/20 0.32
PIM3 Q86V86 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6838074 0.91 ALDH1A1 (0.33) NPY1RALDH1A1KDM4EMAPTHPGD
SCHEMBL6840136 0.91 CCR3 (0.33) NPY1RALDH1A1KDM4EMAPTHPGD
SCHEMBL6838677 0.89 CASR (0.40) NPY1RALDH1A1LMNAKDM4EHPGD
SCHEMBL6838072 0.87 HRH1 (0.35) PIK3R1PIK3CAALDH1A1LMNAKDM4E
SCHEMBL6838542 0.87 PIK3R1 (0.33) PIK3R1PIK3CAALDH1A1LMNAKDM4E
SCHEMBL6837686 0.86 EGFR (0.41) NPY1RPIM1LMNAKDM4EHTT
SCHEMBL7500056 0.85 NPY1R (0.38) NPY1RPIM1CNR2KCNH2CYP1A2
SCHEMBL6838050 0.83 HTR6 (0.38) NPY1RPIM1ALDH1A1KDM4EMAPT
SCHEMBL6838510 0.83 CASR (0.42) NPY1RPIM1CNR2ACP1PIM3
SCHEMBL6837773 0.83 NPY1R (0.38) NPY1RPIM1LMNAKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 NPY1R 1070/4885PIM1 261/4885PIK3R1 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.